English

OSI PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2010-05-06

85 filing records in this dataset, filed from 1995-05-15 to 2010-05-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

107 million USD

2010-03-31 · USD

Exact inputs and evidence

Revenue: 106578000 USD Source

Operating margin

17.77%

2010-03-31 · %

Exact inputs and evidence

Operating Income: 18940000 USD Source
Revenue: 106578000 USD Source

Cash and cash equivalents: 199 million USD 2010-03-31 Source
Exact value

199087000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

441 million USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Revenue: 99066000 USD · 2009-04-01 – 2009-06-30 Source
Revenue: 111447000 USD · 2009-07-01 – 2009-09-30 Source
Revenue: 428148000 USD · 2009-01-01 – 2009-12-31 Source
Revenue: 304190000 USD · 2009-01-01 – 2009-09-30 Source
Revenue: 106578000 USD · 2010-01-01 – 2010-03-31 Source

Net income

64.4 million USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Net income: 16531000 USD · 2009-04-01 – 2009-06-30 Source
Net income: 17566000 USD · 2009-07-01 – 2009-09-30 Source
Net income: 75931000 USD · 2009-01-01 – 2009-12-31 Source
Net income: 50497000 USD · 2009-01-01 – 2009-09-30 Source
Net income: 4851000 USD · 2010-01-01 – 2010-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-05-06.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2009-12-31
Operating income: 10 of 11 periods available· newest 2009-12-31
Net income: 10 of 11 periods available· newest 2009-12-31
operating cash flow: No compatible figures in this window
capital expenditure: No compatible figures in this window
Total assets: 7 of 11 periods available· newest 2009-12-31
Total liabilities: 8 of 11 periods available· newest 2009-12-31
Current assets: 8 of 11 periods available· newest 2009-12-31
Current liabilities: 8 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+12.9%

Prior period

USD 379.39 million

2008-01-01 – 2008-12-31
Current period

USD 428.15 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

428148000 − 379388000 = 48760000 USD

379388000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
428148000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · OSI PHARMACEUTICALS INC · 2009-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Year-over-year change in Revenue: 48760000 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 428148000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#20808 Input fundies:Revenue: 379388000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#20808
The citation records this snapshot. The page link may show a newer release later.
Net income
-82.8%

Prior period

USD 441.59 million

2008-01-01 – 2008-12-31
Current period

USD 75.93 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

75931000 − 441593000 = -365662000 USD

441593000 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
75931000 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · OSI PHARMACEUTICALS INC · 2009-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Year-over-year change in Net income: -365662000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 75931000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#21828 Input fundies:NetIncome: 441593000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#21828
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 428.15 million 100% of revenue
Cost of revenue USD 8.79 million 2.1% of revenue
Operating expenses USD 254.83 million 60% of revenue
Other operating costs Derived USD 11.87 million 2.8% of revenue
Operating income USD 152.65 million 36% of revenue
Tax, interest and other Derived USD 76.72 million 18% of revenue
Net income USD 75.93 million 18% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Operating loss: operating costs were 182% of revenue.
2003 Operating loss: operating costs were 661% of revenue.
2004 Operating loss: operating costs were 688% of revenue.
2005 Operating loss: operating costs were 218% of revenue.
2006 Operating loss: operating costs were 351% of revenue.
2007 18%11%71%
2008 Net income was higher than operating income, so the split is not drawn.
2009 18%18%64%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 1999-10-01 – 2000-09-30	28651428	52264428 Derived	-23613000	-4640000 Derived	-18973000	Unavailable	Source 1999-10-01 – 2000-09-30: 28651428 USD Inspect Revenue Open source 1999-10-01 – 2000-09-30: -23613000 USD Inspect Operating Income Open source 1999-10-01 – 2000-09-30: -18973000 USD Inspect Net Income Open source
2003 2002-10-01 – 2003-09-30	32369000	214082000 Derived	-181713000	-356000 Derived	-181357000	Unavailable	Source 2002-10-01 – 2003-09-30: 32369000 USD Inspect Revenue Open source 2002-10-01 – 2003-09-30: -181713000 USD Inspect Operating Income Open source 2002-10-01 – 2003-09-30: -181357000 USD Inspect Net Income Open source
2004 2003-10-01 – 2004-09-30	42800000	294282000 Derived	-251482000	8889000 Derived	-260371000	Unavailable	Source 2003-10-01 – 2004-09-30: 42800000 USD Inspect Revenue Open source 2003-10-01 – 2004-09-30: -251482000 USD Inspect Operating Income Open source 2003-10-01 – 2004-09-30: -260371000 USD Inspect Net Income Open source
2005 2005-01-01 – 2005-12-31	138423000	301755000 Derived	-163332000	-6209000 Derived	-157123000	Unavailable	Source 2005-01-01 – 2005-12-31: 138423000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -163332000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -157123000 USD Inspect Net Income Open source
2006 2006-01-01 – 2006-12-31	241037000	846029000 Derived	-604992000	-22808000 Derived	-582184000	Unavailable	Source 2006-01-01 – 2006-12-31: 241037000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -604992000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -582184000 USD Inspect Net Income Open source
2007 2007-01-01 – 2007-12-31	341030000	243593000 Derived	97437000	36912000 Derived	60525000	Unavailable	Source 2007-01-01 – 2007-12-31: 341030000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 97437000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 60525000 USD Inspect Net Income Open source
2008 2008-01-01 – 2008-12-31	379388000	246078000 Derived	133310000	-308283000 Derived	441593000	Unavailable	Source 2008-01-01 – 2008-12-31: 379388000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 133310000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 441593000 USD Inspect Net Income Open source
2009 2009-01-01 – 2009-12-31	428148000	275494000 Derived	152654000	76723000 Derived	75931000	Unavailable	Source 2009-01-01 – 2009-12-31: 428148000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 152654000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 75931000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 428.1M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-09-30	Revenue	28651428	Revenue: 28651428 Open source
20032003-09-30	Revenue	32369000	Revenue: 32369000 Open source
20042004-09-30	Revenue	42800000	Revenue: 42800000 Open source
20052005-12-31	Revenue	138423000	Revenue: 138423000 Open source
20062006-12-31	Revenue	241037000	Revenue: 241037000 Open source
20072007-12-31	Revenue	341030000	Revenue: 341030000 Open source
20082008-12-31	Revenue	379388000	Revenue: 379388000 Open source
20092009-12-31	Revenue	428148000	Revenue: 428148000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

12.9% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-09-30	Year over year	No prior comparable period	Revenue: 28651428 Open source
20032003-09-30	Year over year	No prior comparable period	Revenue: 32369000 Open source
20042004-09-30	Year over year	32.2%	Revenue: 42800000 Open source Revenue: 32369000 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 138423000 Open source
20062006-12-31	Year over year	74.1%	Revenue: 241037000 Open source Revenue: 138423000 Open source
20072007-12-31	Year over year	41.5%	Revenue: 341030000 Open source Revenue: 241037000 Open source
20082008-12-31	Year over year	11.2%	Revenue: 379388000 Open source Revenue: 341030000 Open source
20092009-12-31	Year over year	12.9%	Revenue: 428148000 Open source Revenue: 379388000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 35.7% 2009

Net margin 17.7% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-09-30	Operating margin	-82.4%	Operating Income: -23613000 Open source Revenue: 28651428 Open source
20032003-09-30	Operating margin	-561.4%	Operating Income: -181713000 Open source Revenue: 32369000 Open source
20042004-09-30	Operating margin	-587.6%	Operating Income: -251482000 Open source Revenue: 42800000 Open source
20052005-12-31	Operating margin	-118%	Operating Income: -163332000 Open source Revenue: 138423000 Open source
20062006-12-31	Operating margin	-251%	Operating Income: -604992000 Open source Revenue: 241037000 Open source
20072007-12-31	Operating margin	28.6%	Operating Income: 97437000 Open source Revenue: 341030000 Open source
20082008-12-31	Operating margin	35.1%	Operating Income: 133310000 Open source Revenue: 379388000 Open source
20092009-12-31	Operating margin	35.7%	Operating Income: 152654000 Open source Revenue: 428148000 Open source
20002000-09-30	Net margin	-66.2%	Net Income: -18973000 Open source Revenue: 28651428 Open source
20032003-09-30	Net margin	-560.3%	Net Income: -181357000 Open source Revenue: 32369000 Open source
20042004-09-30	Net margin	-608.3%	Net Income: -260371000 Open source Revenue: 42800000 Open source
20052005-12-31	Net margin	-113.5%	Net Income: -157123000 Open source Revenue: 138423000 Open source
20062006-12-31	Net margin	-241.5%	Net Income: -582184000 Open source Revenue: 241037000 Open source
20072007-12-31	Net margin	17.7%	Net Income: 60525000 Open source Revenue: 341030000 Open source
20082008-12-31	Net margin	116.4%	Net Income: 441593000 Open source Revenue: 379388000 Open source
20092009-12-31	Net margin	17.7%	Net Income: 75931000 Open source Revenue: 428148000 Open source
20002000-09-30	Free cash flow margin	Not reported	Revenue: 28651428 Open source
20032003-09-30	Free cash flow margin	Not reported	Revenue: 32369000 Open source
20042004-09-30	Free cash flow margin	Not reported	Revenue: 42800000 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 138423000 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 241037000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 341030000 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 379388000 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 428148000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-09-30	Operating cash flow	Not reported	No source recorded
20032003-09-30	Operating cash flow	Not reported	No source recorded
20042004-09-30	Operating cash flow	Not reported	No source recorded
20052005-12-31	Operating cash flow	Not reported	No source recorded
20062006-12-31	Operating cash flow	Not reported	No source recorded
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	Not reported	No source recorded
20092009-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-09-30	Free cash flow	Unavailable	No source recorded
20032003-09-30	Free cash flow	Unavailable	No source recorded
20042004-09-30	Free cash flow	Unavailable	No source recorded
20052005-12-31	Free cash flow	Unavailable	No source recorded
20062006-12-31	Free cash flow	Unavailable	No source recorded
20072007-12-31	Free cash flow	Unavailable	No source recorded
20082008-12-31	Free cash flow	Unavailable	No source recorded
20092009-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

40% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20002000-09-30	Liabilities / assets	9.9%	Total Liabilities: 9894379 Open source Total Assets: 99776008 Open source
20032003-09-30	Liabilities / assets	63.1%	Total Liabilities: 373445000 Open source Total Assets: 591502000 Open source
20042004-09-30	Liabilities / assets	60.3%	Total Liabilities: 233796000 Open source Total Assets: 388029000 Open source
20052005-12-31	Liabilities / assets	45.4%	Total Liabilities: 480116000 Open source Total Assets: 1058582000 Open source
20062006-12-31	Liabilities / assets	Not reported	Total Liabilities: 429138000 Open source
20072007-12-31	Liabilities / assets	75.1%	Total Liabilities: 419424000 Open source Total Assets: 558380000 Open source
20082008-12-31	Liabilities / assets	45.8%	Total Liabilities: 505658000 Open source Total Assets: 1104203000 Open source
20092009-12-31	Liabilities / assets	40%	Total Liabilities: 473624000 Open source Total Assets: 1185372000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.77× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-09-30	Current assets / current liabilities	12.16×	Current Assets: 87279266 Open source Current Liabilities: 7175043 Open source
20032003-09-30	Current assets / current liabilities	11.89×	Current Assets: 414451000 Open source Current Liabilities: 34853000 Open source
20042004-09-30	Current assets / current liabilities	5.83×	Current Assets: 275445000 Open source Current Liabilities: 47222000 Open source
20052005-12-31	Current assets / current liabilities	2.94×	Current Assets: 418499000 Open source Current Liabilities: 142328000 Open source
20062006-12-31	Current assets / current liabilities	4.35×	Current Assets: 346079000 Open source Current Liabilities: 79583000 Open source
20072007-12-31	Current assets / current liabilities	1.78×	Current Assets: 450125000 Open source Current Liabilities: 252494000 Open source
20082008-12-31	Current assets / current liabilities	11.3×	Current Assets: 690451000 Open source Current Liabilities: 61121000 Open source
20092009-12-31	Current assets / current liabilities	3.77×	Current Assets: 692395000 Open source Current Liabilities: 183529000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 1999-10-01 – 2000-09-30	−USD 18.97 million Exact value Exact value: -18973000 USD 1999-10-01 – 2000-09-30: -18973000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2000-09-30 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -18973000 USD Concept: fundies:NetIncome Period: 1999-10-01 to 2000-09-30 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2000-09-30&surface=latest&period_type=duration&start=1999-10-01&unit=USD&dimensions= Input fundies:NetIncome: -18973000 USD (1999-10-01 to 2000-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-03-004905.txt#1251 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2001 2000-10-01 – 2001-09-30	−USD 21.13 million Exact value Exact value: -21130000 USD 2000-10-01 – 2001-09-30: -21130000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2001-09-30 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -21130000 USD Concept: fundies:NetIncome Period: 2000-10-01 to 2001-09-30 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2001-09-30&surface=latest&period_type=duration&start=2000-10-01&unit=USD&dimensions= Input fundies:NetIncome: -21130000 USD (2000-10-01 to 2001-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-03-013304.txt#3996 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2002 2001-10-01 – 2002-09-30	−USD 218.48 million Exact value Exact value: -218479000 USD 2001-10-01 – 2002-09-30: -218479000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2002-09-30 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -218479000 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: -218479000 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-04-014737.txt#4715 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2003 2002-10-01 – 2003-09-30	−USD 181.36 million Exact value Exact value: -181357000 USD 2002-10-01 – 2003-09-30: -181357000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2003-09-30 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -181357000 USD Concept: fundies:NetIncome Period: 2002-10-01 to 2003-09-30 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2003-09-30&surface=latest&period_type=duration&start=2002-10-01&unit=USD&dimensions= Input fundies:NetIncome: -181357000 USD (2002-10-01 to 2003-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-06-003601.txt#15954 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2004 2003-10-01 – 2004-09-30	−USD 260.37 million Exact value Exact value: -260371000 USD 2003-10-01 – 2004-09-30: -260371000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2004-09-30 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -260371000 USD Concept: fundies:NetIncome Period: 2003-10-01 to 2004-09-30 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2004-09-30&surface=latest&period_type=duration&start=2003-10-01&unit=USD&dimensions= Input fundies:NetIncome: -260371000 USD (2003-10-01 to 2004-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-07-002974.txt#14640 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 157.12 million Exact value Exact value: -157123000 USD 2005-01-01 – 2005-12-31: -157123000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2005-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -157123000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -157123000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-08-002273.txt#10140 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 582.18 million Exact value Exact value: -582184000 USD 2006-01-01 – 2006-12-31: -582184000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2006-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: -582184000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -582184000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-09-003692.txt#21573 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	USD 60.53 million Exact value Exact value: 60525000 USD 2007-01-01 – 2007-12-31: 60525000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2007-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: 60525000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 60525000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#21828 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	USD 441.59 million Exact value Exact value: 441593000 USD 2008-01-01 – 2008-12-31: 441593000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2008-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: 441593000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 441593000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#21828 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	USD 75.93 million Exact value Exact value: 75931000 USD 2009-01-01 – 2009-12-31: 75931000 USD Inspect Net Income Open source Share or cite Citation for Net Income · OSI PHARMACEUTICALS INC · 2009-12-31 OSI PHARMACEUTICALS INC (edgar:729922) Net Income: 75931000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/729922/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 75931000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/729922/0000950123-10-016449.txt#21828 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

85 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000729922, 729922, edgar:729922

Also known as ONCOGENE SCIENCE INC

OSI PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation